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Abstract. Agent based modeling (ABM) and High Performance Computing 
(HPC) techniques are very popular in investigation and understanding cellular 
and molecular systems. The complex nature of these systems and the demand 
for emulation and comprehension at different levels in these models creates the 
expectation for new effective simulation strategies and tools. The present paper 
peruses the foresaid demands and the approaches for developing simulation in 
tumor model and its interactions using ABM and HPC. ABM allows the 
analysis of the actions and interactions of autonomous agents (cells in this case) 
to evaluate their effects on the system as a whole in order to re-create and 
predict the appearance of a complex phenomenon. This is a parametric model 
and it is necessary to explore the data model space to determine which 
combinations of adjustments cause the behaviors which are of interest. In this 
case, HPC is a useful tool to perform experiments in acceptable time.
Keywords: Agent Based Models (ABM), High Performance Simulation, 
Hpcnetlogo, HPC.
1 Introduction
Presumptive and dynamic modeling techniques in different simulators to generate 
complex biological models are promising research tools in oncology, but the need for 
computational techniques for large scale parameters and factors in complex biological 
models has not yet been addressed. Here in this paper, we perused a simulation model 
which has been created based on the agent-based system in Netlogo by Wilensky to 
emulate the development and progression of tumor and metastasis [1].
This model demonstrates the growth of a tumor and how it prevents chemical 
treatment. The tumor mass is recognized as a self-organized and self-regulated model 
of complexity and contains not only inherent properties of tumor cells (e.g., stem 
cells, growth, and migration) but also its interactions with both the immune and the 
vascular system. All types of self-organized immune systems rely on immune cells’ 
capability to produce signaling molecules (e.g., cytokines, antibodies) in reaction to 
the environmental conflicts, which consequently are recognized and lead to the
dynamic changes of their factors and actions [2]. Besides, the blood vessel 
development, or angiogenesis, is controlled by the multiple molecules including 
vascular endothelial growth factor and endothelins. The tumor cells discharge both 
cytokines and angiogenic factors which have strong influence on both the local 
immune system and angiogenic responses of the immune and vascular systems [3].
The sum of the interactions between the tumor, the immune and the vascular local 
systems determines both the success and the rate of tumor progression. The 
complexity of these interactions during tumor progression creates more complex 
interactions that can be modeled and simulated using agent-based systems (ABS) to 
provide a dynamic representation of the tumor development to extract the emergent 
information and knowledge of the system.
Cancer research is generating a large amount of knowledge using information 
provided by the genome. This knowledge can be used, with the support of the 
computational techniques, in addition to those described in the laboratory and clinics 
that can be complex and slow, to create parametric models based on principles/rules 
at the cell level that allow us to understand the emergent behavior of the tumor 
growth/propagation at system level [4, 8].
The high-grade tumor (World Health Organization grade III & IV) expresses a 
cellular hierarchy with the self-renewing called tumorigenic cancer stem cells (CSCs) 
which is an attractive model to explain many aspects of tumor behavior and its 
different growth conditions[8].
Most researches and observation of the cancer stem cell growth has been focused 
on the discovery of mutations and variations of tumor suppressor genes with recessive 
loss of the function. Consequently, the design of the computational models, especially 
multi-agent models and using high performance computing resources and techniques, 
will allow the increase of the knowledge on this subject and will accelerate the 
research and facilitate the clinical experiments. Although it is a promising technique, 
it is very important to consider that the computational models must be validated to 
represent the real system and this may be a complex task, but once this step is done, it 
can be used to understand how CSCs emerge.
This paper is organized as follows; Section 2 describes the research about general 
tumor and cancer models. Section 3 presents the main concepts about the extended 
model used to demonstrate the possibilities of ABM and HPC. In section 4, our 
experimental environment, named HPCNetlogo, is described which is designed to 
facilitate the scientists doing the HPC experimentation without the complexity of high 
performance environment. Section 5 shows the results of the experimentation from 
HPC point of view (speedup, efficiency and scalability of the model) for different 
parametric executions to explore some parts of the possibilities of the model data 
space. Finally, section 6 presents the conclusion and open lines of this work.
2 State of the Art
There is a large set of references where their authors have used probabilistic or 
mathematical models to simulate the growth of active cancer cells using different
phases and cell cycle durations. These models can be classified as oriented toward the 
vasculature without considering the tumor mass or others that determine the 
expansion of the tumor in the presence of non-evolutionary angiogenesis. [9]
However, models have evolved and the tumor mass can be considered as a self­
organized and self-regulated system that includes, in addition to the properties of the 
tumor cells (stem cells, growth, migration, etc.), interactions with the system and 
angiogenesis. This model, which is considered very complex, considers the self­
organization of the immune system (to analyze the immune cells that produce 
signaling molecules) or the evolution of angiogenesis and how they produce dynamic 
changes in the system. [6, 8, 10-12]
Agent based modeling (ABM) is a discrete-based modeling that offers many 
possibilities and advantages over other methods for studying and simulating cancer 
development [6]. ABM allows modelers to study the largest influences on tumor 
behavior by changing factors and parameters and generating repetitions to obtain data 
stability (statistically). There are several types of ABM techniques which have been 
used in cancer research such as lattice-based/free/gas, cellular potts, and sub-cellular 
elements modelling methods [2, 6].
Wilensky’s tumor model [1] in the NetLogo library is used as the base for the 
present case study. This model is designed as a self-organized ABM model that 
illustrates the growth of a tumor and how it resists chemical treatment. In this case the 
model consists of two kinds of cells: stem cells and transitory cells and includes 
controls to kill transitory cells that are younger, to kill a stem cell or moving cells or 
visual information about the total number of living cells or their trajectory.
Considering the complexity of interactions between tumor cells and vascularization 
during tumor progression, the ABM model provides a more dynamic representation of 
the tumor development. However, since the number of parameters and agents required 
to give a realistic approach increases, it is necessary to use high-performance 
computing to make an exploration of the model data space in the acceptable time. In 
addition, since the model includes stochastic variables, it is necessary to perform a 
large set of simulations to obtain statistically acceptable values which the HPC needs.
3 ABM Tumor Model
The design of the agent-based tumor model of the present work is based on the 
Wilensky model [1] and considers the premises stated by Hallmarks of Cancer [5].
In this model two kinds of cells are considered: stem cells and transitory cells. 
Each cell is represented by an agent and tumor cells can breed, move, or die where the 
time is measured in simulation steps (ticks). Initial tumor cells are blue and the cells 
change their color depending on their age (different colors from red palette). A stem 
cell can divide either asymmetrically or symmetrically during the mitosis. In this case 
study, we considered malignant tumors where a symmetric mitosis is followed. In this 
process the stem cell divides symmetrically in two stem cells and the first child of this 
division remains static, but the second cell moves to distant organs to generate a 
metastasis. In this model, we considered only metastasis (and not invasion) as the
mechanism of the spreading cancer cells, reaching it to an organ different from the 
original tumor using blood or lymphatic paths. In the model, the metastasis is red and 
made of cells that die young. As the tumor propagate and get larger, stem cells 
reproduce and die younger.
Moreover, the model includes some considerations about hallmarks listed in [4] 
with the acquired capabilities of cancer:
1. Self-sufficiency in growth signals
2. Insensitivity to antigrowth signals
3. Evading apoptosis
4. Enabling replicative immortality
5. Sustained angiogenesis
6. Cells invasion and metastasis
In order to represent this behavior, the model includes parameters for modeling the 
number of initial stem cells, the growth factor in order to model the self-sufficiency of 
growth signals and insensibility to anti-growth signals, three values to represent the 
apoptosis grade (normal, low, very low) and a replication factor in order to model the 
replicative immortality and angiogenesis capacity of the tumor.
The simulated model represents, with different parameters, the original stem cells, 
the transitory cells, and the metastasis process. The visualization of the tumor grows 
exponentially and the metastasis process is showed as new tumors are allocated 
outside the original location, evolving in an independent location. Figure 1 shows the 
simulation evolution of 6 original stem cells (center) with a random position 
metastasis in new independent tumors with growth-factor=1.25, replication- 
factor=high and apoptosis=normal. In this case, the evolution from the 6 stem cells 
reaches, in steady state, a range of 23,000 to 29,000 cells (agents).
Fig. 1. Stem cells evolution and metastasis visualization (from 6 original stem cells to 23,000­
29,000 in a steady state).
Figure 2 shows the steady state of a tumor metastasis visualization with 6 stem cells 
and the growth-factor=1.75, replication-factor=high, and apoptosis=low. As can be 
seen, the growth of metastasis is more aggressive and through reducing apoptosis, 
there is a greater number of cells that do not die, amounting to near 200,000 cells 
(agents).
Fig. 2. 6 stem cells evolution and metastasis visualization with grow-factor=1.75, 
apoptosis=low and replication-factor=high (near 200,000 cells in steady state).
4 High Performance Approaches for Tumor ABM Model
In agent based model, each cell is represented as an agent with rules, parameters and 
interactions with the environment to reproduce the emergent growth behavior of the 
tumor and metastasis. In this model, all parameters, rules and interactions are 
parametrized and it is easy to adjust a rule or a specific constant for describing 
different tumor behaviors. The main problem of this type of simulation is the higher 
number of parameter combinations that is necessary to explore the data space of the 
model.
Netlogo [1] includes the Behavior Space tool that allows the exploration of the 
model data space using parametric executions in varying settings of the model and for 
recording the results of each model run. This process (p a ra m e te r  sw e e p in g )  permits 
us to explore the model's space of possible behaviors and determine which 
combinations of settings cause the behaviors of interest. The main problem of these 
executions is that the Behavioral Space only supports multithreading, so its 
performance is limited to the number of cores/threads at the local infrastructure.
The solution for this problem is to execute the parametric simulations using a HPC 
cluster in order to reduce the necessary time to explore a determinate model data 
space. This is an interesting idea but, considering HPC cluster complexity, it can be 
complicated for scientists to run these models in an easy way within an HPC cluster.
In order to provide an easy to use and user-friendly solution for non-technical 
users, we have developed a workflow, named HpcNetlogo [13] to deploy the 
simulation of ABM models on a HPC cluster. The execution of this workflow is 
unassisted and the initial user interaction is through an interface based on the web 
technology. In the local environment, the user configures his model, performs the
local tests, sets up the Behavior Space and, through a service, schedule his model, and 
indicates where and how he wants it to be run.
There is a Frontend service that analyzes the user-specified model and generates all 
configuration files required for the proposed simulation scenarios, creates the 
initialization files for the high-performance cluster queue system and then sends them 
to Backend. The backend executes the experiment and when it finishes, the user can 
see the result through the same web interface. HpcNetlogo is open source (GPLV3) 
and can be adapted for different cluster/queue environments (see more information in
[13]). Figure 3 shows the diagram of the architecture and its web interface.
Fig. 3. HPCNetlogo Architecture and Web Interface
5 Results and Discussion
With the objective of analyzing the behavior of the developed model on an HPC 
cluster, a set of simulations with different parameters and values have been performed
to explore, from the point of view of performance, the behavior of the model 
(speedup, efficiency and scalability).
These experiments are the proof of concept considering HPC performance where 
the scalability, number of agents and performance of the model are analyzed but not 
the simulation result as growth factor, apoptosis, angiogenesis or other interesting 
values for an oncologist or researcher in tumor propagation (however these are 
available as simulation results).
The figure 4 shows the speed-up and efficiency for these executions. In this figure, 
the speed-up is close to lineal in the lower number of cores and gets reduced towards 
the higher number of cores. Although the results of speedup and efficiency (about 
80%) seems good, but the main issue is the memory contention problems at the Java 
runtime (Netlogo) for higher core configurations and the I/O from network file system 
(NFS).
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Fig. 4. Speedup and Efficiency for 8 to 256 Cores
Figure 5 shows how scalability effects of the model over the speedup and 
efficiency considering a grow-factor equals to 2.0 and the speedup in compare with 
the values of grow-factor equals to 1.25. This growth-factor, in this case study, 
implies that for the value of 1.25 there are about to 13,000 agents and for the value of 
2, 00 there are about to 110,000 agents. As can be observed, the speedup and 
efficiency are affected by the grow-factor equals to 2.00 but it keeps on showing the 
values performance.
Figure 6 shows the impact of the shared resources at the Java runtime (NFS, memory) 
during the model execution for the larger number of agents: 30 initial stem cells with 
a growth-factor equals to 2.00 that arrives to 361,000 agents (cells). In this case, the 
figure show the distribution of the execution time in a box and whisker plot. As can 
be observed, the model is executed in a fixed number of time units (1,000) at the eight 
cores and runs about 2,234 seconds (average) but on 64 cores it will be run about 
4,417 seconds (average). In order to solve this problem, it is necessary to change 
technology (java runtime) and evolve towards high performance distributed 
simulation environments as Care HPS [14].
Fig. 5. Speedup and Efficiency for 13,000 and 110,000 Agents (cells)
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Fig. 6. Box Diagram of Execution Time for 361,000 Agents
Figure 7 shows the scalability of the model for different number of stem cells 
(from 6 to 60) and to values of grow-factor (1.25 and 1.75). As can be 
observed the scalability of the model is lineal. In this experiment, the 
simulation shows that in the steady state (1.000 simulation steps) for grow- 
factor of 1.25 and 6 initial stem cells the tumor arrived 6.6k agents (cells) 
and for 60 initial stem cells the tumor arrived to 122k agents (cells). For 
growth-factor of 1.75 and 6 initial stem cells, the number of agents (cells) 
was 76k and for 60 initial stem cells the number of agents (cells) augments to 
404k.
It is necessary to remark that employing HPC is extremely necessary because this 
type of analysis is time consuming as can be seen. At these proofs of concepts only 
the minimum number of repetitions to obtain stable statistics data which have been 
executed and only 1000 simulation steps have been performed. It is important to
consider that in other configurations/parameters may be necessary to increase the 
number of simulation steps to justify the necessity of employing HPC for this type of 
experimentation.
Fig. 7. Simulation runtime (average) for growth factors 1.25, 1.75 and from 6 to 60 stem cells
6 Conclusion
In this paper, we introduced a new tumor propagation model based on Wilensky 
model and considering the premises stated by Hallmarks of Cancer and its analysis 
using HPC cluster. For this experimentation, we used an easy-to-use HPC frontend, 
developed by the authors and named HpcNetlogo, that is an environment that allows 
the scientist to execute Netlogo model (in this case study) in an HPC cluster using a 
web interface and the Behavior Space tool included in Netlogo.
As it could be observed, the experiment shows good values for the speed-up and 
efficiency. However the drawback imposed by the Java Virtual Machine and access to 
shared resource is bigger when a high number of agents are used. These limitations 
could be addressed using distributed (non-parametric) simulation environments such 
as Care HPS [14] or Repast HPC [15] to reduce the impact of the shared resources 
access and to execute it with a large number of agents.
The future researches will be oriented toward:
— Detailed validation of the tumor propagation model: it is necessary to compare 
the results of the proposed model with the real data in order to validate the grow 
factor, replication rate and apoptosis factor in order to adjust this values to real 
ones.
— Implementation of tumor propagation model in Care HPS in order to analyze the 
performance values using a distributed simulation environment and its 
scalability for higher number of agents (cells).
— Time limitations prohibited more extensive tests to show performance 
& scalability value for different combinations of the main parameters. It is 
necessary to explore a bigger data space of the model with gradual increase in 
agent creation in order to analyze the impact of these in the simulation execution 
time.
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